logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Enwei Pharmaceuticals: Subsidiary obtains newly issued drug production license.

date
13/02/2026
Enwei Pharmaceuticals announced that its subsidiary, Sichuan Enwei Pharmaceutical Co., Ltd., has obtained the "Drug Production License" issued by the Sichuan Provincial Food and Drug Administration.
Latest
1 m ago
Every Economy AI Flash, Dongwu Securities released a research report on February 13, giving Buy rating to China Taiping (601601.SH). The rating reasons mainly include: (1) Overall operation: steady progress, continuous increase in company value; (2) Personal insurance business: practicing long-termism in life insurance reform, focusing on the value of bank-insurance channel ahead of peers; (3) Property insurance business: clearing credit insurance business does not change the overall high-quality business color; (4) Asset management business: stable allocation style, investment return level is among the top of listed insurance companies. (Daily Economic News)
1 m ago
According to Maoyi AI Express, Dongxing Securities released a research report on February 13th giving a "recommended" rating to Jiangfeng Electronics (300666.SZ). The main reasons for the rating include: 1) planning to acquire control of Kedstone Quartz, strengthening the core competitiveness of the company's semiconductor components business; 2) the market share of advanced manufacturing products continues to increase, with high-purity metal sputtering targets and semiconductor precision components seeing a surge in volume, leading to continuous revenue/profit growth by 2025; 3) steady progress in multiple projects from core materials to precision components. (Daily Economic News)
2 m ago
According to AI Fast News, on February 13th, Pacific Securities issued a research report giving a "buy" rating to Shangri-La Hotel (600258.SH). The reasons for the rating mainly include: 1) Event: Shangri-La Hotel's indirectly wholly-owned subsidiary Home Inn Chain (China) Co., Ltd. plans to invest 280.51 million yuan to build a new hotel property (including renovation and supporting projects) on the original site in Fuhu High-tech Zone, Wujiang District, Suzhou City; 2) This layout is the company's strategic landing to deeply cultivate the mid-to-high-end hotel track, focus on core city clusters, and optimize development models; 3) In terms of regional layout, both projects are located in high-potential core areas, accurately capturing regional development dividends; 4) In terms of product structure, both projects focus on the mid-to-high-end track, accelerating the company's brand upgrades and breaking away from dependence on low-end market; 5) In terms of development model, the "new construction + leasing" dual-mode complements each other, balancing long-term asset accumulation and short-term benefit release. (Daily Economic News)
2 m ago
According to the AI news of Every Economy, on February 12th, Cinda Securities issued a research report giving a "buy" rating to Harls (002615.SZ). The reasons for the rating mainly include: 1) the company's release of equity incentive (draft) and employee stock ownership plan (draft); 2) the confirmation of orders from OEM customers, driving profit improvement by reducing costs and increasing efficiency; 3) multidimensional brand building, with growth potential expected to expand. (Daily Economic News)
2 m ago
Zhongmi Holdings: Currently not participating in solid-state battery projects.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.